Legacy Advisors, LLC Astrazeneca PLC Transaction History

Legacy Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 10, 2019	SELL	$40.12 - $45.47 $46,539 - $52,745	-1,160 Closed	0 $0
Q2 2019 Jul 15, 2019	BUY	$37.28 - $41.68 $43,244 - $48,348	1,160 New	1,160 $48,000
Q4 2017 Jan 26, 2018	SELL	$32.09 - $34.78 $10,172 - $11,025	-317 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$28.96 - $34.0 $9,180 - $10,778	317	317 $10,000

1,368

476M

6.08M

4.44M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $228B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Legacy Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Legacy Advisors, LLC with notifications on news.